CVA Family Office’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.4K | Buy |
393
+162
| +70% | +$20.3K | 0.01% | 547 |
|
|
2025
Q1 | $31.6K | Buy |
231
+96
| +71% | +$13.1K | ﹤0.01% | 595 |
|
|
2024
Q4 | $20.6K | Buy |
135
+20
| +17% | +$3.06K | ﹤0.01% | 672 |
|
|
2024
Q3 | $22.3K | Sell |
115
-198
| -63% | -$38.4K | ﹤0.01% | 637 |
|
|
2024
Q2 | $72.6K | Buy |
313
+171
| +120% | +$39.6K | 0.01% | 424 |
|
|
2024
Q1 | $30.6K | Buy |
142
+2
| +1% | +$431 | 0.01% | 569 |
|
|
2023
Q4 | $36.2K | Buy |
+140
| New | +$36.2K | 0.01% | 528 |
|
|
2023
Q3 | – | Sell |
-115
| Closed | -$32.8K | – | 309 |
|
|
2023
Q2 | $32.8K | Buy |
115
+10
| +10% | +$2.85K | 0.01% | 528 |
|
|
2023
Q1 | $29.2K | Sell |
105
-20
| -16% | -$5.56K | 0.01% | 530 |
|
|
2022
Q4 | $34.6K | Buy |
125
+20
| +19% | +$5.54K | 0.01% | 471 |
|
|
2022
Q3 | $28K | Buy |
105
+35
| +50% | +$9.33K | 0.01% | 470 |
|
|
2022
Q2 | $14K | Sell |
70
-25
| -26% | -$5K | ﹤0.01% | 599 |
|
|
2022
Q1 | $20K | Buy |
95
+5
| +6% | +$1.05K | ﹤0.01% | 556 |
|
|
2021
Q4 | $22K | Buy |
+90
| New | +$22K | 0.01% | 507 |
|
|
2021
Q3 | – | Sell |
-145
| Closed | -$50K | – | 419 |
|
|
2021
Q2 | $50K | Buy |
145
+35
| +32% | +$12.1K | 0.01% | 367 |
|
|
2021
Q1 | $31K | Buy |
+110
| New | +$31K | 0.01% | 334 |
|